Amy Rothberg is an Endocrinology/Metabolic physician affiliated with University of Michigan. OpenAlex indexes 94 publications with 2,383 citations (h-index 25); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
Sponsor: University of Michigan
- The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese Individuals
Sponsor: University of Michigan
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
Sponsor: University of Michigan
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
75.3%GLP-1 receptor agonist38%Ozempic42%Trulicity32%Mounjaro26%Part D<11 patientsInsulin Analog22.7%Lantus Solostar65%Novolog Flexpen35%Part D<11 patients+ 1 more class in this area
Cardiovascular
16%Statin8.7%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker7.3%Amlodipine Besylate100%Part D<11 patientsNervous system
8.7%Aminoketone8.7%Bupropion Xl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Maternal metabolic and molecular changes induced by preconception weight loss and their effects on birth outcomes
University of Michigan at Ann Arbor
FY2024$644,017R01DK124862 - Maternal metabolic and molecular changes induced by preconception weight loss and their effects on birth outcomes
University of Michigan at Ann Arbor
FY2023$795,957R01DK124862 - Maternal metabolic and molecular changes induced by preconception weight loss and their effects on birth outcomes
University of Michigan at Ann Arbor
FY2022$607,509R01DK124862
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”